Skip to main content

PURE Bioscience, Inc.

corporate_fare Company Profile

PURE Bioscience, Inc.

PURE·OTC·Industrial Applications And Services·CIK 0001006028

PURE Bioscience, Inc. is dedicated to developing and commercializing proprietary antimicrobial products that address health and environmental challenges related to pathogen and hygienic control. Its technology platform is based on patented stabilized ionic silver, and its initial products contain Silver Dihydrogen Citrate, or SDC. This broad-spectrum, non-toxic antimicrobial agent is available in liquid form and various concentrations, distinguished by its superior efficacy, reduced toxicity, non-causticity, and the inability of bacteria to develop resistance. The company's SDC-based disinfecting and sanitizing products are registered with the United States Environmental Protection Agency, or EPA, the United States Food and Drug Administration, or FDA, and Health Canada. In addition to manufacturing and distributing these products, PURE Bioscience also supplies SDC-based formulations as raw material ingredients for personal care products. The company sees significant market opportunities for its SDC-based solutions, particularly in the food industry. Its registered offerings include PURE® Hard Surface, a food contact surface sanitizer and disinfectant designed for restaurant chains, food processors, and transportation companies, as well as PURE Control®, a direct food contact processing aid. Products are sold directly to end-use customers, as well as through third-party distributors who market and sell the products across various industries. SDC is an electrolytically generated source of stabilized ionic silver, making it a versatile foundation for a variety of products across diverse markets. Colorless, odorless, tasteless and non-caustic, the aqueous SDC formulates well with other compounds. PURE Bioscience produces and markets pre-formulated, ready-to-use product, as well as varying strengths of SDC concentrate as an additive or raw material for inclusion in other products. SDC is a stabilized silver ion complex with a shelf life of several years; the unique bond between the silver ion in SDC allows the silver ion to remain in solution while at the same time making it more bio-available for antimicrobial action.

PURE Bioscience, Inc. (OTC:PURE) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 11 items for PURE at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-29, rated 8/10. Across its 11 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for PURE spans 10-K, 8-K, 10-Q.

Recent high-impact activity:

  • PURE Bioscience 10-K: Auditors Flag Going Concern as Cash Falls to $569,000
  • PURE Bioscience FY2026: Sales Up 5% to $2.32M, Net Loss Widens to $2.48M, $1.0M of Related-Party Notes Past Due
  • Pure Bioscience Raises $555K in Private Placement; Director Lee Funds Entire Round
  • PURE Bioscience Q3 Net Loss Widens to $624K on $506K Revenue
  • PURE Bioscience Reports Increased Q3 Loss, Raises $1M in Dilutive Private Placement, and Authorizes 92% More Shares

Financial Snapshot

Fiscal year ended July 31, 2026
Revenue
$2.31M
Net Income
-$2.48M
Diluted EPS
-$0.02
Op. Cash Flow
-$1.74M
Gross Profit
$1.33M
Operating Income
-$2.08M
Cash & Equivalents
$569K
Debt / Equity
0.00×
Net Margin
-107.3%
Shares Outstanding
130.02M sh
Source: 10-K · filed 2026-10-29 · accession 0001493152-26-049272

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 1,982 shares in PURE as of the October 30, 2026 settlement, a 54.8% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 1.9% of PURE volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,982 shares as of October 30, 2026
Change vs prior period▼ 54.8%
Days to cover1.00 at avg daily volume of 26,909
Daily short volume (FINRA facilities)1.9% of 37,498 shares on November 20, 2026
5-day average short volume20.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Moderate risk

Filing-implied dilution signals for PURE, detected from its recent SEC filings · based on capital-structure filings through 2026-10-20.

Related-Party Private Placement Closes · Pricing Below Current Market

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with P →
$0.055 +6.59% today
52-week range · as of 2026-10-29 $0.0386 – $0.0999
Market cap
$7.71M
Volume
37.5K (1.6× avg)
3-mo avg 23.4K
Live data · 2026-11-21 12:34 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed PURE - Latest Insights

PURE
Oct 29, 2026, 4:10 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $0.0785
Real-time Price: $0.055 info
Change: -$0.0235 (-30%) info
Market Cap: $7.711M info
PURE
Oct 29, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.0785
Real-time Price: $0.055 info
Change: -$0.0235 (-30%) info
Market Cap: $7.711M info
PURE
Oct 20, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.072
Real-time Price: $0.055 info
Change: -$0.017 (-24%) info
Market Cap: $7.711M info
PURE
Jun 15, 2026, 4:21 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.070
Real-time Price: $0.055 info
Change: -$0.015 (-21%) info
Market Cap: $7.711M info
PURE
Jun 15, 2026, 4:10 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.070
Real-time Price: $0.055 info
Change: -$0.015 (-21%) info
Market Cap: $7.711M info
PURE
Jun 15, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.070
Real-time Price: $0.055 info
Change: -$0.015 (-21%) info
Market Cap: $7.711M info
PURE
May 05, 2026, 5:13 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.067
Real-time Price: $0.055 info
Change: -$0.012 (-18%) info
Market Cap: $7.711M info
PURE
May 05, 2026, 5:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.067
Real-time Price: $0.055 info
Change: -$0.012 (-18%) info
Market Cap: $7.711M info
PURE
Mar 16, 2026, 9:29 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.080
Real-time Price: $0.055 info
Change: -$0.025 (-31%) info
Market Cap: $7.711M info
PURE
Mar 16, 2026, 9:24 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.080
Real-time Price: $0.055 info
Change: -$0.025 (-31%) info
Market Cap: $7.711M info
PURE
Feb 20, 2026, 4:49 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.05672
Real-time Price: $0.055 info
Change: -$0.00172 (-3%) info
Market Cap: $7.711M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets